Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novavax, inc. source : Www.biospace.com save search
Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Published: 2024-02-28 (Crawled : 15:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -22.92%
H: 1.29%
C: -4.96%
year financial results
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024
Published: 2024-02-20 (Crawled : 15:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 0.0%
H: 1.68%
C: -0.72%
conference year financial results
Novavax to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 15:30) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: -2.2%
conference
Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights
Published: 2023-11-09 (Crawled : 14:30) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 1.91%
H: 8.08%
C: -3.17%
financial results
Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023
Published: 2023-11-02 (Crawled : 15:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -0.71%
H: 3.88%
C: 2.73%
conference financial results
Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore
Published: 2023-10-18 (Crawled : 13:30) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -0.78%
H: 2.5%
C: 1.09%
covid-19 vaccine prototype approval
Novavax Advances Science Supporting Protein-based Vaccine Technology at IDWeek 2023 and World Vaccine Congress Europe 2023
Published: 2023-10-11 (Crawled : 14:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 0.68%
H: 9.29%
C: 2.69%
europe vaccine congress world technology
ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS
Published: 2023-08-08 (Crawled : 14:00) - biospace.com/
ENDPQ | $0.0006 -50.0% 3.4K
|
n/a
|
| O: -10.0%
H: 11.11%
C: 0.0%
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 7.98%
H: 8.62%
C: -10.96%
financial results
Novavax Reports Second Quarter 2023 Financial Results and Operational Highlights
Published: 2023-08-08 (Crawled : 13:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 7.98%
H: 8.62%
C: -10.96%
financial results
Novavax to Host Conference Call to Discuss Second Quarter 2023 Financial Results and Operational Highlights on August 8, 2023
Published: 2023-08-01 (Crawled : 15:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -1.51%
H: 1.59%
C: -4.27%
conference financial results
Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses
Published: 2023-05-09 (Crawled : 12:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 20.4%
H: 26.64%
C: 6.13%
covid vaccine positive influenza topline results show
Novavax Reports First Quarter 2023 Financial Results and Operational Highlights
Published: 2023-05-09 (Crawled : 12:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 20.4%
H: 26.64%
C: 6.13%
financial results
Novavax to Host Conference Call to Discuss First Quarter 2023 Financial Results and Operational Highlights on May 9, 2023
Published: 2023-05-02 (Crawled : 16:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -1.04%
H: 1.44%
C: -7.85%
conference financial results
Novavax Grows Presence at World Vaccine Congress 2023 and 33rd European Congress of Clinical Microbiology & Infectious Diseases
Published: 2023-04-04 (Crawled : 14:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -0.41%
H: 1.63%
C: -0.41%
vaccine
U.S. Government and Novavax Extend Partnership, Securing Up to 1.5 Million Additional Doses of Novavax' COVID-19 Vaccine
Published: 2023-02-13 (Crawled : 15:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 1.42%
H: 1.9%
C: -2.4%
covid-19 vaccine
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
Published: 2023-01-18 (Crawled : 14:20) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 1.53%
H: 8.47%
C: -1.19%
covid-19 vaccine approved nuvaxovid
Novavax Announces Pricing of $65 Million Public Offering of Common Stock - December 16, 2022 Novavax, Inc. announced the pricing of an underwritten public offering to sell 6,500,000 shares of its commo...
Published: 2022-12-16 (Crawled : 08:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -15.37%
H: 16.49%
C: 15.14%
offering
Novavax Announces Pricing of $65 Million Public Offering of Common Stock - December 16, 2022
Published: 2022-12-16 (Crawled : 07:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -15.37%
H: 16.49%
C: 15.14%
offering
Novavax Nuvaxovid COVID-19 Vaccine Approved in Canada for Use as a Primary Series in Adolescents
Published: 2022-12-07 (Crawled : 16:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: 0.0%
H: 6.02%
C: 2.62%
covid-19 vaccine canada approved nuvaxovid
Novavax to Participate in BofA Securities 2022 Virtual Biotech SMID Cap Conference
Published: 2022-12-02 (Crawled : 15:00) - biospace.com/
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -2.08%
H: 0.33%
C: 0.12%
conference biotech
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.